复杂主动脉瘤分支腔内修复术后急慢性肾衰竭发生率
该研究分析2012至2020年间139例复杂胸腹主动脉瘤患者接受分支腔内修复(BEVAR)的肾功能变化,术后急性肾损伤发生率为15.8%,出院时11.6%患者CKD分期升高,2年内共5.8%需永久透析,且围术期肾功能恶化与生存率下降显著相关。
要点
- BEVAR术后急性肾损伤发生率为15.8%,出院时11.6%患者CKD分期升高。
- 2年随访期间共5.8%患者需永久透析,其中3例在出院时即依赖透析。
- 高龄、术前血红蛋白<7、主动脉最大直径增大、术后AKI及出院时CKD分期升高与生存率下降显著相关。
核心结论
- BEVAR治疗复杂主动脉瘤后急性肾损伤和慢性肾功能下降仍是突出问题。
- 采用manifold配置的BEVAR术后早中期肾功能结果与分支和/或开窗支架的类似分析相当。
研究设计与样本
- 回顾性分析2012至2020年间139例接受分支腔内修复的复杂胸腹主动脉瘤患者。
- 排除术前已透析患者,采用血清肌酐和估算肾小球滤过率在基线、48小时、出院、1个月、6个月及每年至2年评估肾功能。
主要发现
- 139例患者平均年龄71.13岁,64.7%为男性,共置入530根内脏血管支架。
- 30天、1年和2年全因死亡率分别为5.8%、25.2%和32.4%。
- 中位随访26.9个月(95%CI 21.1-32.7)时,所有血管一期和二期通畅率分别为96.2%和97.5%,肾动脉分别为95.4%和96.9%。
- 术后急性肾损伤22例(15.8%),出院时16例(11.6%)CKD分期升高,其中3例需永久透析;2年随访期间额外5例需永久透析,总计8例(5.8%)。
- 年龄增加(HR=1.0327,P=0.0477)、术前血红蛋白<7(HR=2.4812,P=0.0093)、主动脉最大直径增加(HR=1.0189,P=0.0084)、出现AKI(HR=2.0757,P=0.0182)及出院时CKD分期升高(HR=1.3520,P=0.002)与患者生存率下降显著相关。
临床怎么用
- BEVAR术后应密切监测肾功能,尤其关注高龄、术前贫血、主动脉直径较大及出现AKI或CKD分期升高的患者。
- 出院时CKD分期升高提示长期透析风险增加,需加强随访和肾脏保护策略。
局限性
- 原文未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The purpose of this study was to examine the incidence of acute kidney injury and chronic renal impairment following branched endovascular aneurysm repair (BEVAR) of complex thoracoabdominal aortic aneurysms (TAAA) using the Medtronic Valiant Thoracoabdominal Aortic Aneurysm stent graft system (MVM), the physician-modified Visceral Manifold, and Unitary Manifold stent graft systems. The objective was to report the acute and chronic renal function changes in patients following complex TAAA aneurysm repair. METHODS: This is an analysis of 139 patients undergoing branched endovascular repair for complex TAAAs between 2012 and 2020. Patient renal function was evaluated using serum creatinine and estimated glomerular filtration rate at baseline, 48 hr, discharge, 1 month, 6 months, and annually to 2 years. Patients on dialysis prior to the procedure were excluded from data analysis. RESULTS: A total of 139 patients (mean age 71.13; 64.7% male) treated for TAAA with BEVAR met inclusion criteria and were evaluated. A total of 530 visceral vessels were stented. A majority of patients (n = 131, 94.2%) underwent a single procedure while 8 required staged procedures. Thirty-day, 1-year and 2-year all-cause mortality rates were 5.8%, 25.2%, and 32.4%, respectively. Primary and secondary patency rates at a median follow-up of 26.9 months (95% CI; 21.1 - 32.7) were 96.2% and 97.5% for all vessels and 95.4% and 96.9% for renal arteries, respectively. Postoperative acute kidney injury (AKI) was identified in 22 (15.8%) patients. At discharge, 16 patients (11.6%) had an increase in CKD stage with 3 requiring permanent dialysis. Five additional patients required permanent dialysis over the 2-year follow-up period for a total of 8 (5.8%). Increasing age (HR = 1.0327, P= 0.0477), hemoglobin < 7 prior to procedure (HR = 2.4812, P= 0.0093), increasing maximum aortic diameter (HR = 1.0189, P= 0.0084), presence of AKI (HR = 2.0757, P= 0.0182), and increase in CKD stage (HR = 1.3520, P= 0.002) at discharge were significantly associated with decreased patient survival. CONCLUSIONS: Postoperative AKI and a chronic decline in renal function continue to be problematic in endovascular repair of complex aortic aneurysms. This study found that BEVAR using the manifold configuration resulted in immediate and mid-term renal function that is comparable to similar analyses of branched and/or fenestrated grafts.
引用
- Lommen MJ, Vogel JJ, VandenHull A, et al. Incidence of Acute and Chronic Renal Failure Following Branched Endovascular Repair of Complex Aortic Aneurysms. Ann Vasc Surg. 2021. PMID: 34182119. doi:10.1016/j.avsg.2021.04.045
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。